Căutare | Ifvex

Ifvex

a adăugat un sunet Health
2025-06-13 04:13:21 -

Sumsub: healthtech, fintech sectors most exposed to new wave of AI-powered fraud in APAC
New data released by global verification provider Sumsub, revealed that healthtech and fintech sectors are the most exposed to the new wave of artificial intelligence (AI)- powered fraud in Asia Pacific (APAC). The firm said in a statement on Thursday that APAC digital ecosystems continue to undergo explosive growth, some of the fastest-growing sectors are becoming prime targets for...

0 Commentarii 0 Distribuiri 7K Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Ifvex

a adăugat un sunet Health
2025-02-06 05:37:12 -

Accelerating new drug development with AI in APAC
Clinical trials are becoming increasingly complex highlighting the need for efficiency. At the same time, electronic storage and computing power have increased dramatically and there are more opportunities for data sharing across industry stakeholders as patient data awareness is increasing. With these conditions, AI is poised to make scientific decisions easier and more reliable, therefore,...

0 Commentarii 0 Distribuiri 9K Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Ifvex

a adăugat un sunet Health
2025-05-20 14:20:23 -

How AI is enhancing APAC telehealth
Telehealth services are seeing a major shift in the Asia-Pacific (APAC) region, with artificial intelligence playing a central role. From automated patient monitoring to real-time diagnostics, AI addresses critical healthcare challenges across clinical practices. But how instrumental is AI in helping improve patient outcomes in the region, and where do APAC countries stand in its...

0 Commentarii 0 Distribuiri 10K Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Ifvex

a adăugat un sunet Health
2025-05-09 14:00:50 -

Singapore’s Nuevocor raises $45M Series B for Novel Cardiomyopathy therapy development
Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, has announced the successful completion of $45 million Series B financing. The round was co-led by Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio and Boehringer Ingelheim Venture Fund,...

0 Commentarii 0 Distribuiri 8K Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Ifvex

a adăugat un sunet Health
2025-02-10 17:17:38 -

Using Gen AI in healthcare puts lives on the line – here’s how to mitigate this
As the use of Gen AI tools in the workplace continues to proliferate and starts becoming a staple much like the document software that we use every day, it follows that many end users trust it to deliver faultless answers. Unfortunately, this assumption does not hold true as recent studies have revealed that Gen AI models often provide answers that are less accurate than its confidence level...

0 Commentarii 0 Distribuiri 10K Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!